SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 331 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $35,000 | +6.1% | 467 | +9.1% | 0.00% | +100.0% |
| Q1 2022 | $33,000 | -71.3% | 428 | -66.4% | 0.00% | -75.0% |
| Q4 2021 | $115,000 | -20.7% | 1,273 | -18.9% | 0.00% | -33.3% |
| Q3 2021 | $145,000 | -51.3% | 1,569 | -59.0% | 0.01% | -53.8% |
| Q2 2021 | $298,000 | -23.4% | 3,831 | -26.5% | 0.01% | -35.0% |
| Q1 2021 | $389,000 | -54.3% | 5,212 | +4.2% | 0.02% | -57.4% |
| Q4 2020 | $852,000 | -14.0% | 5,004 | -29.1% | 0.05% | -26.6% |
| Q3 2020 | $991,000 | +11.7% | 7,062 | +27.7% | 0.06% | -1.5% |
| Q2 2020 | $887,000 | +210.1% | 5,529 | +89.1% | 0.06% | +170.8% |
| Q1 2020 | $286,000 | -29.6% | 2,924 | -7.1% | 0.02% | -14.3% |
| Q4 2019 | $406,000 | – | 3,149 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |